• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ETHICON INC. VICRYL POLYGLACTIN 910 SUTURE UNKNOWN PRODUCT; SUTURE, ABSORBABLE, SYNTHETIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ETHICON INC. VICRYL POLYGLACTIN 910 SUTURE UNKNOWN PRODUCT; SUTURE, ABSORBABLE, SYNTHETIC Back to Search Results
Device Problem Material Erosion (1214)
Patient Problems Eye Injury (1845); Not Applicable (3189)
Event Type  Injury  
Manufacturer Narrative
(b)(4).Corneal decompensation, conjunctival erosion, surgical intervention.This report is related to a journal article, therefore no product will be returned for analysis and the batch history records cannot be reviewed as the lot number has not been provided.Attempts are being made to obtain the following information.To date no response has been provided.If further details are received at a later date a supplemental medwatch will be sent.Were the cases discussed in this article previously reported to ethicon? if yes, please provide a complaint reference number.Does the surgeon believe that any deficiency of the ethicon product vicryl suture caused and/or contributed to the adverse events described in the article? citation: can jophthalmol (2017) vol.52,n0.1, 85-91; doi: http://dx.Doi.Org/10.1016/j.Jcjo.2016.06.007.
 
Event Description
It was reported in a journal article title: graft-free ahmed valve implantation through a 6mm scleral tunnel.The purpose of this retrospective cohort study was to evaluate the safety, efficacy, and cost savings of ahmed glaucoma valve (agv) tube implantation through a 6-mm scleral tunnel (graft-free techniques).Between dec2010 and jun2013, 84 eyes from 62 patients (n=27 male, n=35 female; mean age sd 71±16 years) underwent graft-free agv implantation for the treatment of medically uncontrolled elevated intraocular pressure (iop).During the procedure, the conjunctiva was moved forward to cover the plate and a portion of the tube and then sutured to the underlying sclera and surrounding conjunctiva with 7-0 vicryl sutures.6-0 vicryl was utilized as bridle suture.Postoperatively, complications included hyphema (n=15) and corneal decompensation (n=4).After 2-year follow-up, conjunctival erosion (n=2) was noted.Four eyes who had corneal decompensation required agv tube trimming for tube corneal touch; 3 eyes resolved, but 1 eye had persistent corneal decompensation.Our data suggest that the safety and efficacy ofa6mm st is comparable with conventional scleral graft method.Additional information has been requested.
 
Manufacturer Narrative
Therefore this medwatch report is not reportable.Additional information was requested and the following was obtained: does the surgeon believe that any deficiency of the ethicon product vicryl suture caused and/or contributed to the adverse events described in the article? i am here confirming there is no adverse effect reported in my study due to the use of ethicon suture.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VICRYL POLYGLACTIN 910 SUTURE UNKNOWN PRODUCT
Type of Device
SUTURE, ABSORBABLE, SYNTHETIC
Manufacturer (Section D)
ETHICON INC.
p.o. box 151, route 22 west
somerville NJ 08876 0151
Manufacturer (Section G)
ETHICON INC.
Manufacturer Contact
darlene kyle
p.o. box 151, route 22 west
somerville, NJ 08876-0151
9082182792
MDR Report Key7372202
MDR Text Key103516191
Report Number2210968-2018-71668
Device Sequence Number1
Product Code GAM
Combination Product (y/n)N
Reporter Country CodeCA
PMA/PMN Number
K022269
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,l
Reporter Occupation Health Professional
Type of Report Initial,Followup
Report Date 03/06/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/26/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received05/03/2018
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-